Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: J Mol Cell Cardiol. 2016 Aug 15;99:100–112. doi: 10.1016/j.yjmcc.2016.08.009

Table 1.

Cell contractility and Ca2+ transients in cardiomyocytes from WT and RARαKO Mice

WT (n=6) RARαKO (n=7) RARαKO+NAC (n=4)
Cell Contractility
Peak shortening (%) 5.49±0.31 3.37±0.25* 3.81±0.16
+dL/dt (μm/s) 162.3±17.7 86.5±9.56* 134.8±10.6
−dL/dt (μm/s) 104.8±12.2 43.2±7.4* 89.3±13.1
TPS50% (s) 0.058±0.002 0.061±0.002 0.059±0.003
TPS90% (s) 0.096±0.006 0.106±0.006 0.098±0.006
TR50% (s) 0.236±0.016 0.293±0.018* 0.2446±0.026
TR90% (s) 0.411±0.028 0.669±0.052* 0.462±0.033
Tau (s) 0.135±0.009 0.196±0.013* 0.144±0.023
Ca2+ transients
Baseline 1.121±0.019 1.145±0.012 1.148±0.017
dep v 2.354±0.174 2.422±0.142 2.387±0.502
dep v t 0.024±0.002 0.019±0.012 0.021±0.002
bl%peak h 6.538±0.445 6.569±0.477 6.333±1.095
T50CI (s) 0.029±0.002 0.026±0.001 0.027±0.001
T90CI (s) 0.052±0.002 0.048±0.001 0.049±0.001
SR load 0.502±0.041 0.449±0.036 0.476±0.042
ret v 0.658±0.060 0.397±0.017* 0.551±0.028
T50CR(s) 0.249±0.008 0.305±0.007* 0.274±0.007
T90CR (s) 0.546±0.034 0.805±0.052* 0.627±0.016
Tau (s) 0.242±0.009 0.358±0.014*   0.291±0.024

Adult cardiomyocytes isolated from WT and RARαKO mice after 20 wks of gene deletion, treated with or without NAC for 30 min. Cells were field stimulated, mechanical properties and intracellular Ca2+ transients were measured. NAC: N-acetyl-L-cysteine. For cell contractility: TPS50% and TPS90%: time to 50% and 90% of the peak shortening; TR50% and TR90%: time to 50% or 90% cell relengthening; Tau: the exponential decay time constant of the function. For Ca2+ transients: dep v: maximum velocities of Ca2+ transient ratio increase; T50CI and T90CI: time to 50% or 90% of Ca2+ transient ratio increase; ret v: maximum velocities of Ca2+ transient ratio recovery; T50CR and T90CR: time to 50% or 90% of Ca2+ transient ratio recovery; Tau: single exponential intracellular Ca2+ decay. Data are means ± SEM.

*

P<0.05 vs WT;

P<0.05 vs RARαKO.

HHS Vulnerability Disclosure